GenScript Biotech Reports Robust Growth in 2024
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
- Latest
- Trending
Corporation
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
Star Equity enters Energy and Logistics sectors by investing in Enservco. This strategic move diversifies their portfolio.
Asian stocks rise with Wall Street gains, US inflation cheers. Chinese stocks lag, focus on key earnings from big firms.
New SEC rules on climate risk aim to protect investors by ensuring transparency and addressing financial impacts of climate change.
Caledonia Mining boosts Q2 profits with increased gold production and promising project assessments, setting a strong growth path.
Afya's Q2 2024 results show 14% revenue growth, strategic expansions, and a focus on M&A and sustainability.
Stock market sees gains as inflation slows, hinting at possible Fed rate cuts. Key companies in focus include Intel and ...
Terahertz technology market to surge with a CAGR of 16.75%, reaching USD 3.2 billion by 2033, driven by diverse applications.
Northrop Grumman stock reaches $506.98 high, reflecting strong performance and strategic growth in the aerospace and defense sector.
Explore top biotech ETFs like XBI, BBH, and IBB, offering potential returns and portfolio diversification in a growing market.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.